1 / 8

Quantum Dots Market Size and Share: Regional and Global Insights

The Genomics Market size was valued at USD 35.57 Billion in 2024 and the total Genomics revenue is expected to grow at a CAGR of 15.35% from 2025 to 2032, reaching nearly USD 111.51 Billion.<br>

swatimmr
Download Presentation

Quantum Dots Market Size and Share: Regional and Global Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genomics Marketglobal Analysis Report 2025-32 Published by:Swati, Marketing Head

  2. Market Size & Overview: The global genomics market was valued at approximately USD 35.57 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.35% from 2025 to 2032, reaching nearly USD 111.51 billion. Genomics involves the comprehensive study of an organism's entire genetic material, encompassing genes and noncoding DNA. Its applications span various industries, including healthcare, agriculture, biotechnology, and DNA sequencing, facilitating a deeper understanding of genetic tendencies in specific diseases and traits.

  3. Market Growth & Opportunities The genomics market is experiencing significant growth due to increased government funding and investments in genomics projects. For instance, the U.S. Department of Biotechnology initiated the 'Genome India Project,' aiming to collect 10,000 samples to build a reference genome. Similarly, Canada's Ministry of Science and Sport allocated USD 33.4 million to support 36 research projects. The integration of genomic data into clinical workflows enhances personalized medicine, leading to cost savings, improved drug safety, and early disease detection. Technological advancements have reduced the costs of genetic methods, further propelling market growth. Sample Request

  4. Market Segmentation by Test Type Diagnostic Test Genetic Test Newborn Screening Pre-implantation Testing Prenatal Testing Carrier Testing by Product & Service Consumables Systems and software Services by Technology Sequencing Microarray PCR

  5. Regional Analysis: North America: The U.S. is expected to account for a dominant share of 91.6% of the genomics market in North America in 2024. This is attributed to advanced technologies, substantial research funding, government initiatives promoting precision medicine, high public and private investments, and the availability of skilled professionals. Europe: The region demonstrates significant growth in genomics, driven by government funding, technological advancements, and the integration of genomic data into healthcare systems. Countries like the U.K., Germany, and France are at the forefront, with substantial investments in research and development. Asia-Pacific (APAC): The APAC genomics market is projected to register the highest CAGR of 13.8% during the forecast period. In 2024, China is expected to account for 38.9% of the APAC genomics market. Economic growth, increased government focus on healthcare, rapid urbanization, and rising awareness regarding health are driving factors

  6. Regional Analysis Customized Report Request

  7. Merges and Acquisition Thermo Fisher Scientific's Acquisition of Affymetrix: In January 2016, Thermo Fisher Scientific announced its acquisition of Affymetrix for approximately $1.3 billion, which was completed on March 31, 2016. Thermo Fisher Scientific's Acquisition of Affymetrix: In January 2016, Thermo Fisher Scientific announced its acquisition of Affymetrix for approximately $1.3 billion, which was completed on March 31, 2016. Roche's Acquisition of Spark Therapeutics: In February 2019, Roche announced it would acquire gene therapy company Spark Therapeutics for $114.50 per share, totaling approximately $4.3 billion, adding Spark's gene therapy portfolio to its assets. Buy This Report

  8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com

More Related